D. Boral Capital reissued their buy rating on shares of United States Antimony (NYSE:UAMY - Free Report) in a report published on Monday morning,Benzinga reports. D. Boral Capital currently has a $5.00 target price on the stock.
UAMY has been the topic of a number of other reports. HC Wainwright lifted their price target on United States Antimony from $2.60 to $4.50 and gave the stock a "buy" rating in a research note on Friday, May 9th. D Boral Capital raised United States Antimony to a "strong-buy" rating in a research note on Wednesday, April 23rd. B. Riley reissued a "buy" rating on shares of United States Antimony in a report on Tuesday, April 15th. Finally, StockNews.com raised United States Antimony from a "sell" rating to a "hold" rating in a report on Wednesday, May 7th. One investment analyst has rated the stock with a sell rating, four have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, United States Antimony presently has an average rating of "Moderate Buy" and a consensus target price of $3.38.
Check Out Our Latest Stock Report on United States Antimony
United States Antimony Price Performance
NYSE:UAMY traded down $0.08 during mid-day trading on Monday, reaching $2.50. The stock had a trading volume of 1,972,242 shares, compared to its average volume of 2,215,963. The firm has a 50 day moving average price of $2.64 and a two-hundred day moving average price of $1.85. The stock has a market capitalization of $294.81 million, a P/E ratio of -62.50 and a beta of 0.15. United States Antimony has a one year low of $0.25 and a one year high of $3.86. The company has a debt-to-equity ratio of 0.01, a quick ratio of 5.84 and a current ratio of 6.24.
Hedge Funds Weigh In On United States Antimony
Several institutional investors have recently added to or reduced their stakes in UAMY. Kingsview Wealth Management LLC purchased a new position in shares of United States Antimony in the 4th quarter worth approximately $35,000. Cetera Investment Advisers bought a new stake in United States Antimony during the 4th quarter valued at $40,000. Tower Research Capital LLC TRC raised its position in shares of United States Antimony by 2,205.1% in the 4th quarter. Tower Research Capital LLC TRC now owns 26,716 shares of the company's stock worth $47,000 after acquiring an additional 25,557 shares in the last quarter. Jefferies Financial Group Inc. bought a new position in shares of United States Antimony in the 4th quarter worth $52,000. Finally, Financial Sense Advisors Inc. bought a new position in shares of United States Antimony in the 4th quarter worth $53,000. Hedge funds and other institutional investors own 9.49% of the company's stock.
United States Antimony Company Profile
(
Get Free Report)
United States Antimony Corporation produces and sells antimony, silver, gold, precious metals, and zeolite products in the United States, and Canada. It operates through Antimony, Zeolite, and Precious Metals segments. The company offers antimony oxide that is primarily used in conjunction with a halogen to form a synergistic flame retardant system for plastics, rubber, fiberglass, textile goods, paints, coatings, and paper, as well as color fastener in paints and as a phosphorescent agent in fluorescent light bulbs; antimony trisulfide used as a primer in ammunition; and antimony metal for use in bearings, storage batteries, and ordnance.
Featured Stories

Before you consider United States Antimony, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and United States Antimony wasn't on the list.
While United States Antimony currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.